Rapidly Progressive Dementia

Neurologic Clinics

Volumn 25, Issue 3, 2007, Pages 783-807

  Geschwind, Michael D ^a   Haman, Aissa ^a   Miller, Bruce L ^a  

^a Memory and Aging Center Francisco ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HU ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BEHAVIOR CHANGE; BRAIN BIOPSY; CELL INCLUSION; CEREBROSPINAL FLUID; CLINICAL FEATURE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROENCEPHALOGRAM; ENDOCRINE DISEASE; FAHR DISEASE; FRONTOTEMPORAL DEMENTIA; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; IMMUNOCOMPETENCE; INFECTION; LABORATORY TEST; MEDICAL SPECIALIST; METABOLIC DISORDER; NEOPLASM; NERVE DEGENERATION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PARATHYROID DISEASE; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRION DISEASE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE DEMENTIA; REVIEW; SEIZURE; SYMPTOM; THYROID DISEASE; UNITED STATES; VASCULAR DISEASE;

ALGORITHMS; BRAIN DISEASES; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRACTICE GUIDELINES;

EID: 34447308214     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2007.04.001     Document Type: Review

References (150)

1. Korth C., and Peters P.J. Emerging pharmacotherapies for Creutzfeldt-Jakob disease. Arch Neurol 63 4 (2006) 497-501
2. Korth C., May B.C.H., Cohen F.E., et al. Acridine and phenothiazine derivatives as pharmacoptherapeutics for prion disease. Proc Natl Acad Sci U S A 98 17 (2001) 9836-9841
3. Greicius M.D., Geschwind M.D., and Miller B.L. Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry 72 6 (2002) 691-700
4. Tschampa H.J., Neumann M., Zerr I., et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 71 1 (2001) 33-39
5. Poser S., Mollenhauer B., Kraubeta A., et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 122 Pt 12 (1999) 2345-2351
6. Olichney J.M., Galasko D., Salmon D.P., et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51 2 (1998) 351-357
7. WHO. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. Paper Presented at the World Health Organization: Emerging and other communicable diseases, surveillance and control. Geneva (Switzerland), February 9-11, 1998.
8. Masters C.L., Harris J.O., Gajdusek D.C., et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5 2 (1979) 177-188
9. Geschwind M.D., Martindale J., Miller D., et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 60 6 (2003) 813-816
10. Chapman T., McKeel Jr. D.W., and Morris J.C. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology 55 9 (2000) 1396-1397
11. Huang N., Marie S.K., Livramento J.A., et al. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology 61 3 (2003) 354-357
12. Rabinovici G.D., Wang P.N., Levin J., et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology 66 2 (2006) 286-287
13. Geschwind MD, Haman A, Torres-Chae C, et al. Astract P03.135. CSF findings in a large United States sporadic CJD cohort. Neurology 2007;68(Suppl 1):A142.
14. Safar J., Wille H., Itri V., et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4 10 (1998) 1157-1165
15. Safar J.G., Geschwind M.D., Deering C., et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 102 9 (2005) 3501-3506
16. Safar J.G., Wille H., Geschwind M.D., et al. Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A 103 (2006) 11312-11317
17. Lopez O., Claassen D., and Boller F. Alzheimer's disease, cerebral amyloid angiopathy, and dementia of acute onset. Aging (Milano) 3 2 (1991) 171-175
18. Barcikowska M., Mirecka B., Papierz W., et al. A case of Alzheimer's disease simulating Creutzfeldt-Jakob disease. [Polish]. Neurol Neurochir Pol 26 5 (1992) 703-710
19. Caselli R.J., Couce M.E., Osborne D., et al. From slowly progressive amnesic syndrome to rapidly progressive Alzheimer disease. Alzheimer Dis Assoc Disord 12 3 (1998) 251-253
20. Roberson E.D., Hesse J.H., Rose K.D., et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 65 5 (2005) 719-725
21. Litvan I., Mangone C.A., McKee A., et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60 6 (1996) 615-620
22. Caine D., Patterson K., Hodges J.R., et al. Severe anterograde amnesia with extensive hippocampal degeneration in a case of rapidly progressive frontotemporal dementia. Neurocase 7 1 (2001) 57-64
23. Kleiner-Fisman G., Lang A.E., Bergeron C., et al. Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man. Mov Disord 19 5 (2004) 534-543
24. Hodges J.R., Davies R., Xuereb J., et al. Survival in frontotemporal dementia. Neurology 61 3 (2003) 349-354
25. Catani M., Piccirilli M., Geloso M.C., et al. Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity. Dement Geriatr Cogn Disord 17 1-2 (2004) 21-28
26. Haik S., Brandel J.P., Sazdovitch V., et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology 55 9 (2000) 1401-1404
27. McKeith I.G., Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 5 (1996) 1113-1124
28. Walker Z., Allen R., Shergill S., et al. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 15 3 (2000) 267-273
29. Byrne E.J., Lennox G., Lowe J., et al. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52 (1989) 709-717
30. Mitsuyama Y. Presenile dementia with motor neuron disease. Dementia 4 3-4 (1993) 137-142
31. Nasreddine Z.S., Loginov M., Clark L.N., et al. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 45 6 (1999) 704-715
32. Levy M.L., Miller B.L., Cummings J.L., et al. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol 53 7 (1996) 687-690
33. Rosen H.J., Lengenfelder J., and Miller B. Frontotemporal dementia. Neurol Clin 18 4 (2000) 979-992
34. Schneider J.A., Watts R.L., Gearing M., et al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48 4 (1997) 959-969
35. Litvan I., Agid Y., Goetz C., et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48 1 (1997) 119-125
36. Gimenez-Roldan S., Mateo D., Benito C., et al. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm Suppl 42 (1994) 79-90
37. Mathuranath P.S., Xuereb J.H., Bak T., et al. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 68 3 (2000) 304-312
38. Kertesz A., Martinez-Lage P., Davidson W., et al. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55 9 (2000) 1368-1375
39. Avanzino L., Marinelli L., Buccolieri A., et al. Creutzfeldt-Jakob disease presenting as corticobasal degeneration: a neurophysiological study. Neurol Sci 27 2 (2006) 118-121
40. Young G.S., Geschwind M.D., Fischbein N.J., et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26 6 (2005) 1551-1562
41. Grafman J., Litvan I., and Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn 28 3 (1995) 311-320
42. Litvan I., Agid Y., Calne D., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47 1 (1996) 1-9
43. Litvan I., Agid Y., Jankovic J., et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46 4 (1996) 922-930
44. Litvan I., Mega M.S., Cummings J.L., et al. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47 5 (1996) 1184-1189
45. Yagishita A., and Oda M. Progressive supranuclear palsy: MRI and pathological findings. Neuroradiology 38 Suppl 1 (1996) S60-S66
46. Leigh R.J., and Zee D.S. The neurology of eye movements. 3rd edition (1999), Oxford University Press, New York
47. Josephs K.A., Tsuboi Y., and Dickson D.W. Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy. Eur J Neurol 11 5 (2004) 343-346
48. Josephs K.A., Holton J.L., Rossor M.N., et al. Neurofilament inclusion body disease: a new proteinopathy?. Brain 126 Pt 10 (2003) 2291-2303
49. Mackenzie I.R., and Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol 23 4 (2004) 183-193
50. Benke T., Karner E., Seppi K., et al. Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry 75 8 (2004) 1163-1165
51. Mothersead P., Conrad K., Hagerman R., et al. An atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated Tremor/Ataxia syndrome. Appl Neuropsychol 12 3 (2005) 169-178
52. Dropcho E.J. Paraneoplastic diseases of the nervous system. Curr Treat Options Neurol 1 5 (1999) 417-427
53. Gultekin S.H., Rosenfeld M.R., Voltz R., et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123 Pt 7 (2000) 1481-1494
54. Ances B.M., Vitaliani R., Taylor R.A., et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128 Pt 8 (2005) 1764-1777
55. Rosenfeld M.R., Eichen J.G., Wade D.F., et al. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 50 3 (2001) 339-348
56. Dalmau J., Graus F., Villarejo A., et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain 127 Pt 8 (2004) 1831-1844
57. Pittock S.J., Kryzer T.J., and Lennon V.A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56 5 (2004) 715-719
58. Vernino S., Tuite P., Adler C.H., et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 51 5 (2002) 625-630
59. Burton G.V., Bullard D.E., Walther P.J., et al. Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer 62 10 (1988) 2248-2251
60. Mathew R.M., Vandenberghe R., Garcia-Merino A., et al. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68 12 (2007) 900-905
61. Yu Z., Kryzer T.J., Griesmann G.E., et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49 2 (2001) 146-154
62. Honnorat J., Antoine J.C., and Belin M.F. Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?. Ann Neurol 50 5 (2001) 688-691
63. Antoine J.C., Honnorat J., Anterion C.T., et al. Limbic encephalitis and immunological perturbations in two patients with thymoma. J Neurol Neurosurg Psychiatry 58 6 (1995) 706-710
64. Vernino S., Geschwind M.D., and Boeve B. Autoimmune encephalopathies. Neurologist 13 3 (2007) 140-147
65. Buckley C., Oger J., Clover L., et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50 1 (2001) 73-78
66. Pozo-Rosich P., Clover L., Saiz A., et al. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 54 4 (2003) 530-533
67. Thieben M.J., Lennon V.A., Boeve B.F., et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62 7 (2004) 1177-1182
68. Vincent A., Buckley C., Schott J.M., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 Pt 3 (2004) 701-712
69. Bataller L., Kleopa K.A., Wu G.F., et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 78 4 (2007) 381-385
70. Liguori R., Vincent A., Clover L., et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124 Pt 12 (2001) 2417-2426
71. Chang C.C., Eggers S.D., Johnson J.K., et al. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 109 (2007) 54-57
72. Kothbauer-Margreiter I., Sturzenegger M., Komor J., et al. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 243 8 (1996) 585-593
73. Ghika-Schmid F., Ghika J., Regli F., et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?. Mov Disord 11 5 (1996) 555-562
74. Seipelt M., Zerr I., Nau R., et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt- Jakob disease. J Neurol Neurosurg Psychiatry 66 2 (1999) 172-176
75. Henchey R., Cibula J., Helveston W., et al. Electroencephalographic findings in Hashimoto's encephalopathy. Neurology 45 5 (1995) 977-981
76. Bohnen N.I., Parnell K.J., and Harper C.M. Reversible MRI findings in a patient with Hashimoto's encephalopathy. Neurology 49 1 (1997) 246-247
77. Schwartz M.A., Selhorst J.B., Ochs A.L., et al. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol 20 6 (1986) 677-683
78. McCabe D.J., Burke T., Connolly S., et al. Amnesic syndrome with bilateral mesial temporal lobe involvement in Hashimoto's encephalopathy. Neurology 54 3 (2000) 737-739
79. Shein M., Apter A., Dickerman Z., et al. Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev 8 1 (1986) 60-64
80. Peschen-Rosin R., Schabet M., and Dichgans J. Manifestation of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol 41 2 (1999) 79-84
81. Nieuwenhuis L., Santens P., Vanwalleghem P., et al. Subacute Hashimoto's encephalopathy, treated with plasmapheresis. Acta Neurol Belg 104 2 (2004) 80-83
82. Harkness K.A., Coles A., Pohl U., et al. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol 11 1 (2004) 59-62
83. Moore P.M., and Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry 65 1 (1998) 10-22
84. Younger D.S., Hays A.P., Brust J.C., et al. Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology. Arch Neurol 45 5 (1988) 514-518
85. Younger D.S., and Kass R.M. Vasculitis and the nervous system. Historical perspective and overview. Neurol Clin 15 4 (1997) 737-758
86. Ferro J.M. Vasculitis of the central nervous system. J Neurol 245 12 (1998) 766-776
87. Yazici H., Yurdakul S., and Hamuryudan V. Behcet disease. Curr Opin Rheumatol 13 1 (2001) 18-22
88. Briani C., Baracchini C., Zanette G., et al. Rapidly progressive dementia in hypereosinophilic syndrome. Eur J Neurol 8 3 (2001) 279-280
89. Bruzelius M., Liedholm L., and Hellblom M. Celiac disease can be associated with severe neurological symptoms. Analysis of gliadin antibodies should be considered in suspected cases[Swedish]. Lakartidningen 98 34 (2001) 3538-3542
90. Caselli R.J., Boeve B.F., Scheithauer B.W., et al. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology 53 7 (1999) 1579-1581
91. Schielke E., Nolte C., Muller W., et al. Sarcoidosis presenting as rapidly progressive dementia: clinical and neuropathological evaluation. J Neurol 248 6 (2001) 522-524
92. Rabinstein A.A., Romano J.G., Forteza A.M., et al. Rapidly progressive dementia due to bilateral internal carotid artery occlusion with infarction of the total length of the corpus callosum. J Neuroimaging 14 2 (2004) 176-179
93. Auchus A.P., Chen C.P., Sodagar S.N., et al. Single stroke dementia: insights from 12 cases in Singapore. J Neurol Sci 203-4 (2002) 85-89
94. Hunder G.G., Arend W.P., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33 8 (1990) 1065-1067
95. American College of Rheumatology. Bibliography of criteria, guidelines, and health status assessments used in rheumatology. American College of Rheumatology. Available at: http://rheumatology.org/publications/abbreviations/. Accessed October 10, 2005.
96. Josephson S.A., Papanastassiou A.M., Berger M.S., et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg 106 1 (2007) 72-75
97. Wynne P.J., Younger D.S., Khandji A., et al. Radiographic features of central nervous system vasculitis. Neurol Clin 15 4 (1997) 779-804
98. Heinrich A., Vogelgesang S., Kirsch M., et al. Intravascular lymphomatosis presenting as rapidly progressive dementia. Eur Neurol 54 1 (2005) 55-58
99. Menendez Calderon M.J., Segui Riesco M.E., Arguelles M., et al. Intravascular lymphomatosis. A report of three cases. [Spanish]. An Med Interna 22 1 (2005) 31-34
100. Brew B.J. AIDS dementia complex. Neurol Clin 17 4 (1999) 861-881
101. Wallace M.R., Nelson J.A., McCutchan J.A., et al. Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment. Sex Transm Infect 77 3 (2001) 199-201
102. Nath A., Maragos W.F., Avison M.J., et al. Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol 7 1 (2001) 66-71
103. Navia B.A., and Price R.W. The acquired immunodeficiency syndrome: dementia as the presenting sole manifestation of human immunodeficiency virus infection. Arch Neurol 44 (1987) 65-69
104. Ala T.A., Doss R.C., and Sullivan C.J. Reversible dementia: a case of cryptococcal meningitis masquerading as Alzheimer's disease. J Alzheimers Dis 6 5 (2004) 503-508
105. Heckman G.A., Hawkins C., Morris A., et al. Rapidly progressive dementia due to Mycobacterium neoaurum meningoencephalitis. Emerg Infect Dis 10 5 (2004) 924-927
106. Glaser C.A., Honarmand S., Anderson L.J., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43 12 (2006) 1565-1577
107. Timmermans M., and Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 75 12 (2004) 1727-1730
108. Fox P.A., Hawkins D.A., and Dawson S. Dementia following an acute presentation of meningovascular neurosyphilis in an HIV-1 positive patient. AIDS 14 13 (2000) 2062-2063
109. Kaplan R.F., and Jones-Woodward L. Lyme encephalopathy: a neuropsychological perspective. Semin Neurol 17 1 (1997) 31-37
110. Waniek C., Prohovnik I., Kaufman M.A., et al. Rapidly progressive frontal-type dementia associated with Lyme disease. J Neuropsychiatry Clin Neurosci 7 3 (1995) 345-347
111. Andersson C., Nyberg C., and Nyman D. Rapid development of dementia of an elderly person, diagnosis and successful treatment. [Finnish]. Duodecim 120 15 (2004) 1893-1896
112. Wormser G., Dattwyler R., Nowakowski J., et al. Diagnosis and treatment of Lyme disease in the United States. Resid Staff Physician (April, 2001) 15-25
113. Kouyoumdjian J.A. Subacute sclerosing panencephalitis in an adult: report of a case. [Portuguese]. Arq Neuropsiquiatr 43 3 (1985) 312-315
114. Espay A.J., and Lang A.E. Infectious etiologies of movement disorders. In: Roos K.L. (Ed). Principles of Neurologic Infectious Diseases (2005), McGraw-HilL, New York 383-408
115. Anderson M. Neurology of Whipple's disease. J Neurol Neurosurg Psychiatry 68 1 (2000) 2-5
116. Durand D.V., Lecomte C., Cathebras P., et al. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore) 76 3 (1997) 170-184
117. Louis E.D., Lynch T., Kaufmann P., et al. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol 40 4 (1996) 561-568
118. Matthews B.R., Jones L.K., Saad D.A., et al. Cerebellar ataxia and central nervous system whipple disease. Arch Neurol 62 4 (2005) 618-620
119. Singer R. Diagnosis and treatment of Whipple's disease. Drugs 55 5 (1998) 699-704
120. Ramzan N.N., Loftus Jr. E., Burgart L.J., et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 126 7 (1997) 520-527
121. Bataille B., Delwail V., Menet E., et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92 2 (2000) 261-266
122. Bakshi R., Mazziotta J.C., Mischel P.S., et al. Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord 10 2 (1999) 152-157
123. Carlson B.A. Rapidly progressive dementia caused by nonenhancing primary lymphoma of the central nervous system. AJNR Am J Neuroradiol 17 9 (1996) 1695-1697
124. Rollins K.E., Kleinschmidt-DeMasters B.K., Corboy J.R., et al. Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol 36 3 (2005) 282-290
125. Haman A, DeArmond S, Johnson JK, et al. When CJD is not CJD. Paper Presented at the 131st Annual Meeting of the American Neurological Association. Chicago (IL), October 8-11, 2006.
126. Batchelor T., and Loeffler J.S. Primary CNS lymphoma. J Clin Oncol 24 8 (2006) 1281-1288
127. Fetell M.R. Lymphomas. In: Rowland L. (Ed). Merrit's textbook of neurology. 9th edition (1995), Williams & Wilkins, Baltimore (MD) 351-359
128. Kuker W., Nagele T., Korfel A., et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72 2 (2005) 169-177
129. Abrey L.E., DeAngelis L.M., and Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 16 3 (1998) 859-863
130. Zuckerman D., Seliem R., and Hochberg E. Intravascular lymphoma: the oncologist's "great imitator". Oncologist 11 5 (2006) 496-502
131. Balmaceda C.M. Lymphomas. In: Rowland L.P. (Ed). Merritt's Neurology. 10th edition (2001), Lippincott Williams & Wilkins, New York 344-350
132. Vieren M., Sciot R., and Robberecht W. Intravascular lymphomatosis of the brain: a diagnostic problem. Clin Neurol Neurosurg 101 1 (1999) 33-36
133. Chapin J.E., Davis L.E., Kornfeld M., et al. Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand 91 6 (1995) 494-499
134. Rivas E., Sanchez-Herrero J., Alonso M., et al. Miliary brain metastases presenting as rapidly progressive dementia. Neuropathology 25 2 (2005) 153-158
135. Kinsella L.J., and Riley D.E. Nutritional deficiencies and syndromes associated with alcoholism. In: Goetz C. (Ed). Textbook of Clinical Neurology. Chapter 40. 2nd edition (2003), Saunders, St. Louis, MO
136. Cummings J.L., and Benson D.F. Dementia in vascular and infectious disorders. Dementia: a clinical approach (1983), Butterworths, Boston p. 125-67
137. Ishii N., and Nishihara Y. Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases. J Neurol Neurosurg Psychiatry 44 3 (1981) 209-215
138. Geschwind MD, Jay C. Assessment of rapidly progressive dementias. Concise review related to chapter 362: Alzheimer's disease and other primary dementias in Harrison's Textbook of Internal Medicine. New York: McGraw Hill. Available at: http://harrisons.accessmedicine.com/. Accessed June 6, 2007.
139. Kertesz S.G. Pellagra in 2 homeless men. Mayo Clin Proc 76 3 (2001) 315-318
140. Chu K., Kang D.W., Kim H.J., et al. Diffusion-weighted imaging abnormalities in wernicke encephalopathy: reversible cytotoxic edema?. Arch Neurol 59 1 (2002) 123-127
141. Unlu E., Cakir B., and Asil T. MRI findings of Wernicke encephalopathy revisited due to hunger strike. Eur J Radiol 57 1 (2006) 43-53
142. Halavaara J., Brander A., Lyytinen J., et al. Wernicke's encephalopathy: is diffusion-weighted MRI useful?. Neuroradiology 45 8 (2003) 519-523
143. Marcao A.M., Wiest R., Schindler K., et al. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene. Arch Neurol 62 2 (2005) 309-313
144. Letournel F., Etcharry-Bouyx F., Verny C., et al. Two clinicopathological cases of a dominantly inherited, adult onset orthochromatic leucodystrophy. J Neurol Neurosurg Psychiatry 74 5 (2003) 671-673
145. Hinkebein J.H., and Callahan C.D. The neuropsychology of Kuf's Disease: a case of atypical early onset dementia. Arch Clin Neuropsychol 12 1 (1997) 81-89
146. Gorbach S.L. Bismuth therapy in gastrointestinal diseases. Gastroenterology 99 3 (1990) 863-875
147. Jungreis A.C., and Schaumburg H.H. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology 43 6 (1993) 1265
148. Gordon M.F., Abrams R.I., Rubin D.B., et al. Bismuth toxicity. Neurology 44 12 (1994) 2418
149. Benet L.Z. Safety and pharmacokinetics: colloidal bismuth subcitrate. Scand J Gastroenterol Suppl 185 (1991) 29-35
150. Hampel H., Berger C., and Muller N. A case of Ganser's state presenting as a dementia syndrome. Psychopathology 29 4 (1996) 236-241